Activation of the classical complement pathway occurs when immune complexes interact with the first component, C 1, to convert it from its inactive precursor form to an active esterolytic enzyme, CI. 1 CI by producinglimited proteolysis of C4 and C2 produces the classical pathway (23 convertase, C42 (1). The alternative pathway is activated when the complex surface polysaccharides of bacteria or yeasts come into contact with serum (2). As a consequence of this contact, C3b, the major cleavage product of C3; factors B (B) 2 and D (17)); and properdin (P) interact to assemble the alternative pathway C3 and C5 convertases (3, 4). Activation of the complement system results in the generation of phlogistic molecules from C2, B, C3, and (35 which act on the membranes of lymphocytes, macrophages, polymorphonuclear leukocytes, mast cells, platelets, and smooth muscle cells (5), all of which may be involved in the inflammatory response.
regulatory proteins, C3bINA and fl 1H with each other and with the other components of the alternative pathway (11) (12) (13) (14) . These correlations have been used to emphasize the importance of serum concentrations of these proteins in the modulation of turnover of the alternative pathway. However, it is uncertain whether these correlations are accounted for by catabolic mechanisms or whether the synthetic rates of these proteins are governed by common factors.
In recent years it has become obvious that at least three cell types synthesize complement proteins, the hepatocytes, the epithelial cells of the gastrointestinal and genitourinary tracts, and cells of the monocyte-maerophage series (15) . Human monocytes and/or maerophages have been shown to synthesize C 1 and its subcomponents (16) , C4 (17, 18) , C2 (18) (19) (20) , and C3 (17, 18, 21) .
In this paper, evidence is presented to show that the human peripheral blood monocyte in short-term tissue culture synthesizes all the components of the alternative pathway and its control proteins and, in addition, C4, C2, and C5.
Materials and Methods
Preparation of Monocyte Monolayers. Peripheral blood mononuclear cells were isolated by centrifugation on Ficoll (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.) -Hypaque (Winthrop Laboratories, New York) cushions (22) . The cells were washed three times with Eagle's minimum essential medium (MEM; Gibco-Biocult Ltd., Paisley, Scotland) and the cells finally resuspended in RPMI-1640 (Gibco-Biocult Ltd.) containing 20% heatinactivated (2 h, 56°C) fetal calf serum (RPMI.FCS) to a concentration of 1 × 107/mi. Purified monocyte monolayers were prepared by layering 1 ml of cell suspensions onto a 22-mm ~quare glass coverslip contained in a 35-× 10-ram plastic Petri dish (Nunc Laboratories, Oslo, Norway). The Petri dishes were incubated at 37°C in a humidified atmosphere of 5% CO2 and air for 2 h. After incubation, the coverslips were washed vigorously with warm MEM to remove nonadherent cells and then overlayed with 2 ml RPMI.FCS and reincubated at 37°C in a humidified 5% CO2 and air atmosphere. Using this technique, between five and seven cultures were prepared from each blood donation.
All the cells contained in monolayers prepared in this manner stained positively for nonspecific esterase (23) , and most phagocytosed Candida albicans. None of the cells rosetted with unsensitized sheep erythrocytes (24) , but >90% rosetted with EA (7S) (25) and EA43 (19S) (26) showing that they possessed both Fc and C3b receptors. Using fluorescein-labeled anti-Ig (Burroughs-Wellcome Ltd., Beckenham, Kent, England), unfixed monolayers were stained for surface Ig, but none of the cells showed positive staining.
Sampling of Cultures and Storage of Samples.
To demonstrate the presence of complement proteins in the culture, 200-/~1 samples of supernate were removed on days 1-9, samples from cultures from the same donor were pooled, and on day 12, the total supernate was harvested. The removed culture fluid was replaced by an equal volume of fresh RPMI.FCS. In one experiment, three cultures were set up and the culture medium changed daily for 10 d to study cumulative complement protein synthesis. (34) , and fllH (35) were purified and antisera to C 4, C3, C5, B, P, C3bINA, and flirt produced by immunization of rabbits with the purified proteins in complete Freund's adjuvant. Anti-C2 was a gift from Dr. Hans J. Miiller-Eberhard, Scripps Clinic and Research Foundation, La Jolla, Calif. Functionally~ purified C3, C5, C6, C7, C8, and C9 (Cordis Laboratories Inc., Miami, Fla.) were used in C3 and C5 hemolytic assays. Rat serum diluted 1 to 15 in 0.04 M EDTA.GVB" (C-rat) was used as a source of C3-C9 in the C4, C2, B, P, D, C3bINA, and fllH hemolytic assays. Serum depleted of I5 (RD) was prepared by the gel filtration of fresh human serum over a 5.0-X 100-cm column of Sephadex G75 superfine (Pharmacia Fine Chemicals, Inc., Uppsala, Sweden). The exclusion peak was rechromatographed over the same column, concentrated to the original serum volume, and was unable to l.,yse rabbit erythrocytes (E tab) in Mg.EGTA (36) . Lysis was restored by the addition of purified D, but not P or B. E mb were separated from rabbit blood collected in Alsever's solution and stored at 0°C until used. EAC4 were prepared by the method of Borsos and Rapp (37) .
Functional Assays. C2 (38) , C4 (28) , and C3 and C5 (39) were measured by standard stoichiometric hemolytic assays. B. EAC43b were prepared by incubating EAC142 (1 × 10S/ml DGVB +÷) with an equal volume of DGVB ++ containing 10/tg/ml C3 at 37°C for 30 min. Conversion to EAC43b was achieved by incubating EAC1423b in 0.01 M EDTA.GVB-for 2 h at 37°C. EAC43b were standardized to 1 X 10S/ml DGVB ++. 100 #l of DGVB ++ containing I) (10 U/ml) and P (250 ng/ml), 50/tl of culture supernate, and 100 gl of EAC43b were mixed and incubated at 30°C for 30 min. 300 gti of C-rat were added to each tube, followed by a further incubation at 37°C for 1 h. The reaction was stopped by the addition of 2 ml 0.15 M saline, and after centrifugation, the degree of lysis was measured spectrophotometrically at 4!4 nm. Controls included cell blank Q00/~1EAC43b + 450 gl DGVB++), reagent blank (100/~1EAC43h, 100#1DGVB ++ containing D and P, 50 lal RPMI.FCS, and 300/zl C-rat), 100% lysis (same as reagent blank by lysed in 2 ml distilled water) and complement color (250 #! DGVB ++ and 300 lal C-rat). Results were expressed as number of hemolytic sites (Z) = -In(1 -y); where y = proportion of cells lysed.
P. EAC43b (1 × 10S/ml DGVB ++) prepared as described for the B assay, were incubated at 30°C for 30 min with an equal volume of DGVB ++ containing ID (10 U/ml) and sufficient B to ~roduce five hemolytic sites. The cells, EAC43b--'~'~ were centrifuged and resuspended 1 × 10/ml in ice-cold 0.01 M EDTA.GVB-. 100/tl of EAC43bBb were incubated with an equal volume of supernate diluted 1 to 2 in 0.02 M EDTA.GVB" at 30°C for 15 min. After the addition of 0.3 ml C-rat and a further 1-h incubation at 37°C, 2 ml of 0.15 M saline was added to each tube to stop the reaction, and after centrifugation, the degree of lysis was measured spectrophotometrically at 414 nm. Controls included cell blank (100 lal EAC43bBb, 400 gl DGVB++), reagent blank (100 gl EAC43b, I00 #1 supernate diluted 1 to 2 in 0.02 M EDTA.DGVB', and 300 lal C-rat), solo (100 gi EAC43bBb, 100 #1 RPMI.FCS diluted 1 to 2 in 0.02 M EDTA.GVB=, and 300 gl C-rat), 100% lysis (same as control, except lysed in 2 ml distilled water), complement color (200 gl DGVB ++, 300 #1 C-rat). The number of hemolytic sites per tube (Z) was calculated, and the number resulting from P activity was calculated by subtracting the control result from the test result.
The kinetics of decay of C3-'b-~ in the presence of monocyte culture medium and RPMI.FCS was investigated. EAC43bBb (1 × 10S/ml 0.01 M EDTA.GVB') prepared as described, were mixed with an equal volume of monocyte culture medium or RPMI.FCS diluted 1 to 2 in 0.02 M EDTA.GVB-at 30°C. 200-#1 samples were taken at 5, 10, 15, and 30 min, added to 300 #1 C-rat, and incubated for a further 1 h at 37°C. After termination of the reaction, hemoglobin release was measured spectrophotometrically.
fllH. EAC43bBb, prepared as described for the P assay, were suspended to 1 × 10a/ml in 0.01 M EDTA.GVB =. The convertase was stabilized by the addition of P (250 ng/ml). The resultant EAC43bBbP (100 #1) were incubated at 30°C for 15 rain with 100 gl of supernate diluted 1 to 2 in 0.02 M EDTA.GVB=. The residual EAC43bBbP hemolytic sites were developed by the further incubation for 1 h in the presence of 300 #1 C-rat. The reaction was stopped by the addition of 2 ml 0.15 M saline, and after centrifugation the degree of hemoglobin release was determined spectrophotometrically. Controls included cell blank (100 pl EAC43bBbP, 400 pl DGVB++), reagent blank (100 pl EAC43b, 100/~1 RPMI.FCS diluted 1 to 2 in 0.02 M EDTA.GVB •, and 300/xl C-rat), control (100 #1 EACr43bBbP, 100 #1 RPMI.FCS diluted 1 to 2 in 0.02 M EDTA.GVB-, and 300 pl C-rat), 100% lysis (as for control, but lysed in 2 ml distilled water). The results were expressed in Z' units, where Z' ---In of (1 -the percentage of inactivation) which is: C3blNA. EAC43b, carrying limited C3b hemolytic sites were prepared using an R3 reagent as previously described (12) . 100 pl EAC43b (1 × 10S/ml 0.01 M EDTA.DGVB', pH 6.0) were incubated with 50 pl culture supernate in 100 #1 0.01 M EDTA.DGVB', pH 6.0, for 1 h at 376C. After two washes in DGVB ++, the cells were resuspended in 100 #1 DGVB ++ and incubated with 100 #1 DGVB ++ containing B (2 ng/ml) and I) (10 U/ml) for 30 min at 30°C. C3bBb sites were developed by incubation with 300 pl C-rat for 1 h at 37°C. 2 ml of 0.15 M saline were added to stop the reaction, and after centrifugation the degree of lysis was measured spectrophotometrically at 414 nm. All controls were incubated with 50 #1 RPMI.FCS in 100 /xl 0.01 M EDTA.DGVB-(pH 6.0) during the first incubation, and during the second incubation as follows: cell blank (100 #1 EAC43b, 400 #1 DGVB++), reagent blank (100 pl EAC43b, 100 /~1 DGVB ++, and 300 #1 C-rat), control (100 #1 EAC43b, 100 #1 DGVB ++ containing B [2 #g/ml] and D [10 U/ml], and 300 #1 C-rat), 100% lysis (same as reagent blank, but lysed in 2 ml distilled water). Results were expressed as Z' units in the same way as the ]~IH results (above). /3. 100 pl of E ~b (1 × 10S/ml Mg.EGTA) were incubated for 30 minutes at 30°C with 25 pl culture supernate and 100 pl RD diluted 1 to 5 in Mg.EGTA. Excess C3-C9 was introduced by the addition of 300 #1 C-rat followed by a further incubation of I h at 37°C. The reaction was stopped by the addition of 2 ml 0.15 M saline, and after centrifugation, the degree of lysis rab was measured speetrophotometrieally at 414 nm. Controls included cell blank (100 pl E ,425 pl Mg.EGTA), reagent blank (100 pl E tab, 25 pl RPMI.FCS, 100 #! RD diluted 1 to 5 in Mg.EGTA, and 300 #1 C-rat), 100% lysis (as for reagent blank, but lysed in 2 ml distilled water), complement color (25 pl RPMI.FCS, 100 pl RD, 150/d Mg.EGTA, and 300 #1 C-rat). Results were expressed as effective molecules of I~. In a separate experiment, monocyte culture fluid was incubated with 10 -3 M diisopropyl fluorophosphate (DFP) (Sigma Chemical Co.) to inhibit D activity (41) .
Radioimmunoassay for ~IH. /~IH (1 pg) was radiolabeled with 1125 (IBS3; Radiochemical
Centre, Amersham, Buckinghamshire, England) by the method of Hunter and Greenwood (42) . The monomeric radiolabeled protein was separated from aggregated ~IH, and from the free iodide gel by filtration on an Ultrogel AcA 34 (LKB Ltd., London, England) column (1.0 × 50 cm). Fractions containing 12~I were tested for their ability to precipitate with anti-/31H, and the fractions containing immunoprecipitable protein were pooled, aliquoted, and stored at -70°C. Sp act of IzSI-labeled ,/~IH preparations ranged from 30 to 70 pCi/pg.
Concentrations of,B1H in monocyte culture supernates were measured using the double antibody technique (43) . The diluent buffer used was phosphate-buffered saline (PBS; containing 0.01 M phosphate, 0.3 M NaCI, 1% bovine serum albumin, pH 7.4). 100/tl of supernate was incubated with 100/~1 of rabbit anti-,B1H (diluted 1 to 5,000 in PBS), 100 pg 125I-fllH in 100 #1 PBS, and 300 pl PBS at 4°C overnight. Antibody-bound x25I-~lH was precipitated by the addition of 100 pl normal rabbit serum (Burroughs-Wellcome Ltd.) diluted 1 to 25 in PBS, followed by a further incubation for 24 h at 0°C. Samples were centrifuged at 4°C for 30 min at 3,000 rpm, the supernates were removed, and the radioactivity present in the precipitate was measured in an automatic gamma counter (Nuclear Chicago, High Wycombe, England). A standard curve was constructed by including unlabeled/~IH at concentrations ranging from 200 ng/ml to 20 pg/ml. The assay was significantly sensitive to detect 500 pg/ml ofl~lH in the culture fluid. RPMI.FCS did not influence the assay. All samples were treated in duplicate, and duplicate samples differing by > 10% of each other were repeated. Radiolabeled (4C) valine and leucine (Radiochemical Centre) were added to RPMI.FCS to a final concentration of 25 /~Ci/ml. Culture fluids were harvested on day 5, pooled, extensively dialyzed against isotonic veronal-buffered saline (pH 7.4), lysophilized and redissolved in normal human serum. This serum was then tested by double immunodiffusion in 1.5% agarose plates, against antisera to C4, C3, C5, fllH, B, C3bINA, for 2 d followed by washing for 1 d in deionized water. Plates were air-dried, covered in plastic wrap (Perfawrap, High Wycombe, England), applied to x-ray film (Curix, RP1; Agfa Gevaert, Antwerp, Belgium) for 6 wk at room temperature in the dark, the film developed (Kodak D19, Eastman Kodak, Manchester, England) and the incorporation of radiolabel into immunoprecipitable protein studied.
Incorporation of Radiolabeled Amino Acids into Immunoprecipitable Protein.

Immunoperoxidase Localization of Complement Protein in Monocytes.
Cultures of monocytes were prepared and incubated for 7 d as described above. The culture fluid was removed, the monolayers washed in warm MEM, fixed in 2.5% glutaraldehyde for 30 rain at room temperature, and washed in Tris-buffered saline (0.15 M, pH 7.2). After blocking of endogenous peroxidase activity with acidified methanol containing hydrogen peroxide, monolayers were stained for C2, C4, C3, C5, B, P, C3bINA, or fllH by the immunoperoxidase bridge method (44) . Negative controls were included in each run, and specificity of staining was confirmed by blocking experiments using purified protein preparations. Swine anti-rabbit IgG and peroxidase-anti-peroxidase immune complexes were obtained from Burroughs-Wellcome Ltd.
Results
Kinetics of Synthesis of Complement Proteins by Monocytes.
Culture supernates were examined for C2, C4, C3, C5, B, D, P, C3bINA, and ,81H functional activity. C4, C3, and fllH were never detected, but it appeared that small quantities of functionally active C5 were produced in some cultures. Evidence for the production of C2, B, I), P, and C3bINA was obtained by functional assay, and for fllH production by radioimmunoassay. The kinetics of production of all proteins were similar (Fig. 1) , a slight delay in the onset of synthesis was less marked for I7) and C3bINA, followed by a rapid increase in synthesis between days 1 and 4, and finally, a plateau after day 5. On day 6, the following mean concentrations were: for C2 (29 X 10 -7 effective molecules/culture :tz 3.2 × 10 -7 SD), B (133 × 10 -7 effective molecules/culture + 37 × 10 -7 SD), g) (85 X 10 -7 effective molecules/culture :1:7.5 x 10 -7 SD), C3blNA (45 Z' U/culture :i: 11.6 SD), and fllH (9.8 ng/culture + 2.2 ng SD).
In the assays for C2, B, 17), and P, the number of hemolytic sites (Z) produced varied linearly with input of supernate added (Fig. 2) . The volume of supernate also showed a linear relationship to the number of Z' units produced in the C3bINA assay (Fig. 2) .
Monocyte culture fluid retarded the decay ofC3bBb, the half-life of the convertase exposed to RPMI.FCS was 4 min and that exposed to monocyte culture fluid was 8 min (Fig. 3) . 17) activity in monocyte culture fluid was completely inhibited by 10 -8 M DFP.
Cumulative Synthesis of Complement Proteins.
In three cultures set up in duplicate, the culture medium was Changed daily (Fig. 4) . The quantities of C2, B, I7), P, C3bINA, and fllH synthesized per day were added, and it was found that after day 1, synthesis continued at a constant rate up to day 10 without a plateau being reached. The slight flattening of the curve between days 9 and 10 probably reflects death of cells in the cultures. The slopes of the six graphs are very similar.
Cyctoheximide-induced Inhibition of Synthesis. Incorporation of cycloheximide (1.0/~g/ ml) into the culture medium produced inhibition of C2, B, I~, P, C3bINA, and fllH synthesis (Fig. 5) . When the cyeloheximide-containing medium was removed the 
Incorporation of t+C-labeled Amino Acids into Immunoprecipitable Protein.
As can be seen in Fig. 6 , a4C-labeled amino acids were incorporated into G4, C3, C5, t~, P, C3bINA, and/31H. Culture fluids containing cyeloheximide (1.0/~g/ml) failed to show incorporation of 14C-labeled amino acids into protein.
Immunoperoxidase Localization of Complement Proteins. All the monoeytes in each
culture stained for C4, C2, C3, C5, B, P, G3bINA, and ~IH (Fig. 7) . Virtually all the cells in each culture stained positively for all the proteins studied. The cytoplasm of monoeytes which had retained their rounded shape throughout the period of culture stained densely, whereas monocytes which had spread showed a dense granular possessed Fc and C3b receptors, and phagocytosed C. albicans, coupled with the observations that they lacked sheep erythrocyte receptors and surface Ig, and their morphological appearances all suggested that the cells were monocytes free from lymphocytes and polymorphonuclear leukocyte contamination. Previous studies (18) (19) (20) have shown that human monocytes in culture are capable of synthesizing C2, an observation we have used in these experiments to test the ability of our cultures to synthesize a complement protein, which also verifies these previous reports.
Evidence has been provided ( Table I , summary_) that monocytes in addition to synthesizing C2, also synthesize C4, C3, C5, B, D, P, C3bINA, and fllH. Using functional assays, B, D, P, and C3bINA activity were found (Fig. 1) whereas C4, C3, and fllH activities could not be detected, although the assays used would detect 200,000 effective molecules of C4 and 40,000 effective molecules of C3 per ml of a standard pool of human serum, and 20 ng/ml of fllH. However, using a radioimmunoassay, increasing concentrations of fllH were found in the culture supernates (Fig. 1) . In addition to the functional assays described, P activity was capable of stabilizing C3bBb (Fig. 3) and I~ activity inhibited by DFP (10 -a M) . Incorporation of cycloheximide (1.0 ~g/ml) into the culture medium resulted in reversible inhibition of C2, B, 15, P, C3bINA, and fllH synthesis (Fig. 5) . 14C-labeled amino acids were incorporated into C4, C3, C5, B, P, C3bINA, and /~IH protein (Fig. 5) , but incorporation into l~ could not be tested for because of lack of suitable antiserum.
Finally, using the immunoperoxidase technique, C2, C4, C3, C5, B, P, C3bINA, and /~IH were found in all the cultured cells ( Fig. 7) which is in agreement with findings of Einstein et al. (18) who found lysozyme was present in all human monocytes in culture. This may not mean that all monocytes are synthesizing these proteins; it is equally possible that only subpopulations have this property and the remainder pinocytose, or adsorb onto their surfaces, the newly synthesized proteins. Ultrastructural localization studies will discriminate among these possibilities. From the failure to detect functionally active C4, C3, or ~I H and the irregular detection of C5 activity, it could be argued that the detection of ~4C-labeled amino acids in the immunoprecipitable proteins could represent nonspecific binding to the carrier proteins (15) . However, the immunoperoxidase localization studies, the cycloheximide-induced inhibition of X4C-labeled amino acids into immunoprecipitable protein, and the detection of f l l H by radioimmunoassay, all argue against this possibility. Three other explanations are possible: (a) monocytes synthesize and secrete precursor molecules which require proteolytic cleavage to be converted to the active molecule (45), (b) molecules are synthesized in active form, but are enzymatically degraded in the culture fluid, and (c) their concentrations may be too low to permit detection in the functional assays employed. C4 is apparently synthesized by monocytes as the single polypeptide chain, pro-C4, whereas C3 is present as a double polypeptide chain, and therefore has presumably been degraded in the culture fluid after synthesis (H. R. Colten. Personal communication.). The explanation why ~OlH was not detected functionally in the assay described here, could be a result of the low concentrations of the protein found (5 ng/ml) in the culture fluids (Fig. 1) . In experiments investigating the mechanism of destabilization of C3bBbP b y /~I H , it was difficult to detect concentrations of fllH <20 ng/ml (10, 35) . It is also possible that fllH is secreted into the culture fluid as an inactive pro-fllH molecule: this possibility is currently under investigation.
The detection of hemolytically active B in these experiments is at variance with results obtained using guinea pig macrophage culture supernates, in which all the B is inactivated after its synthesis in the presence of functionally active D and C3, (46) . The inactivation process probably depended upon cleavage of B by I) during the assembly of the alternative pathway C3 convertase in the culture fluid. The ability to detect hemolytically active C3 in guinea pig macrophage cultures must be because the amount of C3bBb formed in the culture fluid is limited by the availability of B, when D and (23 are in excess. In contrast, in the human monocyte system described here, the limiting factor must be C3 as B and D are detected: either insufficient (]3 is synthesized to turnover all the B produced, or the C3 is incapable of participating in the formation of a (23 convertase because it is in the form of an inactive precursor, or has been somehow degraded after synthesis.
It has previously been shown that proteolytic enzymes can substitute for I) in the formation of C3bBb (47) and therefore, in the absence of immunoperoxidase localization with specific anti-I) antibody, it is possible that other monocyte-derived enzymes could be responsible for the D-like activity measured. Likewise, it is conceivable that certain lysozomal hydrolases could inactivate C3b; and thus the C3bINA activity observed could be a result of a combination of the actions of C3bINA and/or other enzymes. Molecular characterization of D and C3bINA activities in monocyte culture fluid should resolve these problems.
The recent observations that human peritoneal macrophages synthesize hemolytically active C~ and its three subcomponents (16) , together with the data presented in this communication, demonstrate that cells of the human monocyte-macrophage series are capable of synthesizing all the components which should ultimately be capable of forming the C3 and C5 convertases of both the classical and alternative pathways. Macrophages from laboratory animals are also capable of synthesizing the components of the classical and alternative pathways (15, 16, 46, 48) but have not been shown to produce C3bINA or flirt. By synthesizing C5, they produce the three proteins, C3, C5, and B, which are currently thought to provide most of the major phlogistic cleavage products of complement' activity. The mobile nature of this source of complement components could have important consequences on the development of the local inflammatory reaction. The synthesis of the regulatory proteins C3bINA and fllH may be important in modulating the extent of complement activation at such sites.
The similarity of the observed rates of synthesis of C2, B, [), P, C3bINA, and fll H (Fig. 2) suggest that action of a common controlling factor or factors, which could account for the correlation between the serum levels of these proteins.
Summary
Short-term cultures of human peripheral blood monocytes were shown to synthesize the alternative pathway complement components C3, factors B (B) and I) (D), and properdin, the regulatory proteins (23b inactivator (C3bINA) and fllH, in addition to C2, C4, and C5. B, l), properdin, C3bINA, and C2 were detected by functional assays, whereas fllH, C4, C3, and t25 could only be detected using immunochemical procedures. Immunoperoxidase localization studies showed that all the cells in each culture contained each component, so it is possible that all monocytes synthesize each component.
It is concluded that cells of the monocyte-macrophage series form a mobile source of complement components and regulatory proteins which can be concentrated at sites of inflammation.
